Rise in BNP despite appropriate acute decompensated heart failure treatment: Patient characteristics and outcomes;BNP-Anstieg trotz angemessener Therapie einer akut dekompensierten Herzinsuffizienz: Eigenschaften und Ergebnisse der Patienten

Herz

Volumn 42, Issue 4, 2017, Pages 411-417

  Omar, H R ^a   Guglin, M ^b  

^a Mercy Medical Center   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

B type natriuretic peptide; Congestion; Mortality; Prognosis; Pulmonary capillary wedge pressure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; SODIUM;

ACUTE HEART FAILURE; ADULT; AGE; ARTICLE; BREATHING DISORDER; DEATH; EXHALATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INSPIRATORY CAPACITY; JUGULAR VEIN; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORTHOPNEA; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; SYSTOLIC HEART FAILURE; VEIN DILATATION; WEIGHT REDUCTION; ACUTE DISEASE; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; UNITED STATES; UPREGULATION;

ACUTE DISEASE; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; UNITED STATES; UP-REGULATION;

EID: 84987608284     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-016-4478-5     Document Type: Article

References (16)

1. Fruhwald FM, Fahrleitner-Pammer A, Berger R (2007) Early and sustained effects of cardiac resynchronization therapy on N terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J 28:1592–1597
2. Kazanegra R, Cheng V, Garcia A et al (2001) A rapid test for B‑type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7:21–29
3. Anand IS, Fisher LD, Chiang YT et al (2003) For the Bal-HeFT Investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107:1278–1283
4. Bettencourt P, Azevedo A, Pimenta J et al (2004) N‑terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110(15):2168–2174
5. Latini R, Masson S, Wong M et al (2006) Incremental prognostic value of changes in B‑type natriuretic peptide in heart failure. Am J Med 119(1):70.e23–70.e30
6. Cohen-Solal A, Logeart D, Huang B et al (2009) Lowered B‑type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. J Am Coll Cardiol 53:2343–2348
7. Di Somma S, Magrini L, Pittoni V et al (2010) In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study. Crit Care 14(3):R116.8
8. Anand IS, Fisher LD, Chiang YT et al (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107(9):1278–1283
9. Shah MR, Hasselblad V, Stinnett SS et al (2001) Hemodynamic profiles of advanced heart failure: association with clinical characteristics and long-term outcomes. J Card Fail 7(2):105–113
10. Binanay C, Califf RM, Hasselblad V et al (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294:1625–1633
11. Drazner MH, Hellkamp AS, Leier CV et al (2008) Value of clinician assessment of Hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail 1:170–177
12. Omar HR, Guglin M (2016) Discharge BNP is a stronger predictor of 6‑month mortality in acute heart failure compared with baseline BNP and admission-to-discharge percentage BNP reduction. Int J Cardiol 221:1116–1122
13. Omar HR, Guglin M (2016) Longitudinal BNP follow-up as a marker of treatment response in acute heart failure: Relationship with objective markers of decongestion. Int J Cardiol 221:167–170
14. Omar HR, Guglin M (2016) A single BNP measurement in acute heart failure does not reflect the degree of congestion. J Crit Care 33:262–265
15. Omar HR (2015) Acute cardiogenic pulmonary edema with normal BNP: the value of repeat BNP testing. Am J Emerg Med 33(4):605.e5–605.e6
16. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. doi:10.1002/ejhf.592